Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Tables)

v3.21.2
Net Income (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Schedule of reconciliation of the numerators and denominators used in computing basic and diluted net income (loss) per share attributable to common stockholders
The following table provides the numerators and denominators used in computing basic and diluted net income (loss) per share attributable to Envestnet, Inc.:
  Three Months Ended Nine Months Ended
  September 30, September 30,
  2021 2020 2021 2020
(in thousands, except share and per share data)
Net income (loss) attributable to Envestnet, Inc. (a)
$ 11,740  $ 1,910  $ 18,405  $ (10,350)
Weighted-average common shares outstanding:
Basic (b)
54,547,858  53,800,048  54,400,247  53,464,101 
Effect of dilutive shares:
Options to purchase common stock 201,103  331,728  207,281  — 
Unvested restricted stock units 570,515  610,442  614,005  — 
Convertible Notes —  730,267  —  — 
Warrants 69,151  86,498  66,439  — 
Diluted (c)
55,388,627  55,558,983  55,287,972  53,464,101 
Net income (loss) per share attributable to Envestnet, Inc common stock:
Basic (a/b)
$ 0.22  $ 0.04  $ 0.34  $ (0.19)
Diluted (a/c)
$ 0.21  $ 0.03  $ 0.33  $ (0.19)
Schedule of anti-dilutive securities excluded from computation of diluted earnings per share
Securities that were anti-dilutive and therefore excluded from the computation of diluted net income (loss) per share were as follows:
Three Months Ended Nine Months Ended
  September 30, September 30,
  2021 2020 2021 2020
Options to purchase common stock —  —  —  556,252 
Unvested RSUs and PSUs —  —  —  1,766,715 
Warrants —  —  —  470,000 
Convertible Notes 9,898,549  4,848,044  9,898,549  9,898,549 
Total anti-dilutive securities 9,898,549  4,848,044  9,898,549  12,691,516